Skip to main content

See also:

FDA invites public to cosmetics regulation meeting

The International Cooperation on Cosmetics Regulation meeting in July 2013 yielded only "agreement to provide additional information" from industry on endocrine disruptors.
The International Cooperation on Cosmetics Regulation meeting in July 2013 yielded only "agreement to provide additional information" from industry on endocrine disruptors.
Photo by Sean Gallup

FDA has announced its pre-meeting to prepare for the International Cooperation on Cosmetics Regulation (ICCR-8) meeting to be held in Canada from July 8 through July 10, 2014. The public is invited to register for the pre-meeting, scheduled for the afternoon of June 4, 2014, in College Park, Maryland. Individuals interested in attending or presenting at the meeting are instructed to contact Maria Cook by May 20, 2014. Accommodations for individuals with disabilities are available, but must be requested by May 28.

The ICCR-8 will be the eighth time that cosmetics regulatory bodies from several nations have met to discuss cooperation on the regulation of "cosmetic-like drug and quasi-drug products." At ICCR-7, which was held in July 2013 in Tokyo, Japan, participants discussed alternatives to animal testing, the use of nanomaterials and endocrine disruptors, and allergens and trace impurities in cosmetics. Participants at ICCR typically include staff from regulators such as FDA, as well as employees of cosmetic firms such as L'Oreal and Procter & Gamble.

At ICCR-7, representatives from the cosmetics industry agreed to provide future ICCR participants with information and "a proposal for future discussion" on the topic of endocrine disruptors in cosmetics. Chemicals such as parabens and phthalates that are commonly used in makeup and fragrances have been shown to cross the placenta during pregnancy and to disrupt sexual development of offspring in utero.